Medicamen Biotech

Founded in 1993, Medicamen Biotech Limited is a leading force in the pharmaceutical industry with robust infrastructure for research, development, and production. The company's vision is to emerge as a preferred pharmaceutical company, leading in quality, market share, and profit by fostering a high-performance culture. Its core purpose is to enhance the quality of life, which is supported by a mission to provide high-quality, affordable medicines globally. It manufactures a diverse product portfolio including general medicine, pain management, cardiology, and is now making a strategic leap into oncology treatments. The company implements a dual distribution strategy, combining its own sales efforts with strategic partnerships to ensure its products are widely available worldwide. A key achievement highlighting its global market ambition is the successful filing of its first ANDA with the USFDA for Bortezomib Injection.;